Regenerative medicine seeks to replace lost, damaged or diseased tissue with new, healthy tissue through procedures not requiring organ donation and transplantation. Regenerative therapies have not been developed for most organ systems, including the brain, heart, kidney, pancreas, and joints. While strategies in the past decade have focused on potential therapies involving treatment with cell populations, tapping into natural regeneration programs and boosting the endogenous capacity of tissue to regenerate or rejuvenate is a prerogative for the field today. This is where the discovery science of developmental and regeneration biology and the application of regenerative medicine must meet and work together closely.
Duke Regeneration Center seeks to accomplish this goal, by bringing faculty, trainees and staff together to advance education, discovery science, translational research, and development of therapies.
Drs. Ken Poss and David Sherwood awarded with a Pew Innovation Fund to study the coordinated signaling process that takes place within the body during tissue repair and regeneration. Click here to read more.
Delisa Clay of the Fox Lab is excited to announce her first author paper was accepted by the Journal of Cell Biology. The title of the paper is “Persistent DNA Damage Signaling and DNA Polymerase Theta Promote Broken Chromosome Segregation”.
Duke Regeneration Center launched July 1, 2021!
Regeneromics services available now! More information under Regeneromics tab in the menu.